[(1S,2S,6S,9S,10S,11R,12R,13S,14S,15S,16R,18S,19R,20S,22S,23S,25R)-20-acetyloxy-10,12,14,16,23-pentahydroxy-6,10,19-trimethyl-13-[(2S)-2-methylbutanoyl]oxy-24-oxa-4-azaheptacyclo[12.12.0.02,11.04,9.015,25.018,23.019,25]hexacosan-22-yl] (2S)-2-hydroxy-2-methylbutanoate
Internal ID | 31f36cdb-4511-417e-bc48-4be6677c578f |
Taxonomy | Lipids and lipid-like molecules > Steroids and steroid derivatives > Steroidal alkaloids > Cerveratrum-type alkaloids |
IUPAC Name | [(1S,2S,6S,9S,10S,11R,12R,13S,14S,15S,16R,18S,19R,20S,22S,23S,25R)-20-acetyloxy-10,12,14,16,23-pentahydroxy-6,10,19-trimethyl-13-[(2S)-2-methylbutanoyl]oxy-24-oxa-4-azaheptacyclo[12.12.0.02,11.04,9.015,25.018,23.019,25]hexacosan-22-yl] (2S)-2-hydroxy-2-methylbutanoate |
SMILES (Canonical) | CCC(C)C(=O)OC1C(C2C(CN3CC(CCC3C2(C)O)C)C4C1(C5C(CC6C7(C5(C4)OC6(C(CC7OC(=O)C)OC(=O)C(C)(CC)O)O)C)O)O)O |
SMILES (Isomeric) | CC[C@H](C)C(=O)O[C@H]1[C@@H]([C@H]2[C@@H](CN3C[C@H](CC[C@H]3[C@@]2(C)O)C)[C@H]4[C@@]1([C@@H]5[C@@H](C[C@H]6[C@]7([C@]5(C4)O[C@@]6([C@H](C[C@@H]7OC(=O)C)OC(=O)[C@](C)(CC)O)O)C)O)O)O |
InChI | InChI=1S/C39H61NO13/c1-9-19(4)32(44)52-31-29(43)28-21(17-40-16-18(3)11-12-25(40)36(28,8)47)22-15-37-30(38(22,31)48)23(42)13-24-35(37,7)26(50-20(5)41)14-27(39(24,49)53-37)51-33(45)34(6,46)10-2/h18-19,21-31,42-43,46-49H,9-17H2,1-8H3/t18-,19-,21-,22-,23+,24-,25-,26-,27-,28+,29+,30+,31-,34-,35+,36+,37+,38-,39-/m0/s1 |
InChI Key | RCDFKDXMJYWZIU-PUCXWOGFSA-N |
Popularity | 1 reference in papers |
Molecular Formula | C39H61NO13 |
Molecular Weight | 751.90 g/mol |
Exact Mass | 751.41429100 g/mol |
Topological Polar Surface Area (TPSA) | 213.00 Ų |
XlogP | 1.60 |
Atomic LogP (AlogP) | 1.04 |
H-Bond Acceptor | 14 |
H-Bond Donor | 6 |
Rotatable Bonds | 7 |
There are no found synonyms. |
![2D Structure of [(1S,2S,6S,9S,10S,11R,12R,13S,14S,15S,16R,18S,19R,20S,22S,23S,25R)-20-acetyloxy-10,12,14,16,23-pentahydroxy-6,10,19-trimethyl-13-[(2S)-2-methylbutanoyl]oxy-24-oxa-4-azaheptacyclo[12.12.0.02,11.04,9.015,25.018,23.019,25]hexacosan-22-yl] (2S)-2-hydroxy-2-methylbutanoate 2D Structure of [(1S,2S,6S,9S,10S,11R,12R,13S,14S,15S,16R,18S,19R,20S,22S,23S,25R)-20-acetyloxy-10,12,14,16,23-pentahydroxy-6,10,19-trimethyl-13-[(2S)-2-methylbutanoyl]oxy-24-oxa-4-azaheptacyclo[12.12.0.02,11.04,9.015,25.018,23.019,25]hexacosan-22-yl] (2S)-2-hydroxy-2-methylbutanoate](https://plantaedb.com/storage/docs/compounds/2023/11/4caa1400-85d8-11ee-abd8-a5126038f15a.jpg)
Target | Value | Probability (raw) | Probability (%) |
---|---|---|---|
Human Intestinal Absorption | + | 0.6715 | 67.15% |
Caco-2 | - | 0.8604 | 86.04% |
Blood Brain Barrier | + | 0.7250 | 72.50% |
Human oral bioavailability | - | 0.6143 | 61.43% |
Subcellular localzation | Lysosomes | 0.6149 | 61.49% |
OATP2B1 inhibitior | - | 0.7365 | 73.65% |
OATP1B1 inhibitior | + | 0.8873 | 88.73% |
OATP1B3 inhibitior | + | 0.9480 | 94.80% |
MATE1 inhibitior | - | 0.9000 | 90.00% |
OCT2 inhibitior | - | 0.8000 | 80.00% |
BSEP inhibitior | + | 0.6896 | 68.96% |
P-glycoprotein inhibitior | + | 0.7508 | 75.08% |
P-glycoprotein substrate | + | 0.7289 | 72.89% |
CYP3A4 substrate | + | 0.7442 | 74.42% |
CYP2C9 substrate | - | 1.0000 | 100.00% |
CYP2D6 substrate | - | 0.7867 | 78.67% |
CYP3A4 inhibition | - | 0.8309 | 83.09% |
CYP2C9 inhibition | - | 0.9078 | 90.78% |
CYP2C19 inhibition | - | 0.9025 | 90.25% |
CYP2D6 inhibition | - | 0.9308 | 93.08% |
CYP1A2 inhibition | - | 0.9425 | 94.25% |
CYP2C8 inhibition | + | 0.7358 | 73.58% |
CYP inhibitory promiscuity | - | 0.9613 | 96.13% |
UGT catelyzed | - | 0.6000 | 60.00% |
Carcinogenicity (binary) | - | 1.0000 | 100.00% |
Carcinogenicity (trinary) | Non-required | 0.5302 | 53.02% |
Eye corrosion | - | 0.9891 | 98.91% |
Eye irritation | - | 0.9116 | 91.16% |
Skin irritation | - | 0.7598 | 75.98% |
Skin corrosion | - | 0.9349 | 93.49% |
Ames mutagenesis | - | 0.5552 | 55.52% |
Human Ether-a-go-go-Related Gene inhibition | - | 0.4759 | 47.59% |
Micronuclear | + | 0.5500 | 55.00% |
Hepatotoxicity | + | 0.5849 | 58.49% |
skin sensitisation | - | 0.8817 | 88.17% |
Respiratory toxicity | + | 0.6333 | 63.33% |
Reproductive toxicity | + | 0.9000 | 90.00% |
Mitochondrial toxicity | + | 0.9750 | 97.50% |
Nephrotoxicity | + | 0.6634 | 66.34% |
Acute Oral Toxicity (c) | I | 0.8149 | 81.49% |
Estrogen receptor binding | + | 0.6791 | 67.91% |
Androgen receptor binding | + | 0.7508 | 75.08% |
Thyroid receptor binding | - | 0.5771 | 57.71% |
Glucocorticoid receptor binding | + | 0.7008 | 70.08% |
Aromatase binding | + | 0.6573 | 65.73% |
PPAR gamma | + | 0.7271 | 72.71% |
Honey bee toxicity | - | 0.6602 | 66.02% |
Biodegradation | - | 0.7250 | 72.50% |
Crustacea aquatic toxicity | + | 0.5100 | 51.00% |
Fish aquatic toxicity | + | 0.7302 | 73.02% |
Proven Targets:
CHEMBL ID | UniProt ID | Name | Min activity | Assay type | Source |
---|---|---|---|---|---|
No proven targets yet! |
Predicted Targets (via Super-PRED):
CHEMBL ID | UniProt ID | Name | Probability | Model accuracy |
---|---|---|---|---|
CHEMBL253 | P34972 | Cannabinoid CB2 receptor | 99.89% | 97.25% |
CHEMBL4261 | Q16665 | Hypoxia-inducible factor 1 alpha | 99.61% | 85.14% |
CHEMBL3251 | P19838 | Nuclear factor NF-kappa-B p105 subunit | 99.10% | 96.09% |
CHEMBL4303 | P08238 | Heat shock protein HSP 90-beta | 97.76% | 96.77% |
CHEMBL2996 | Q05655 | Protein kinase C delta | 96.53% | 97.79% |
CHEMBL4681 | P42330 | Aldo-keto-reductase family 1 member C3 | 95.31% | 89.05% |
CHEMBL4478 | Q00975 | Voltage-gated N-type calcium channel alpha-1B subunit | 93.33% | 97.14% |
CHEMBL1907603 | Q05586 | Glutamate NMDA receptor; GRIN1/GRIN2B | 93.32% | 95.89% |
CHEMBL2534 | O15530 | 3-phosphoinositide dependent protein kinase-1 | 92.80% | 95.36% |
CHEMBL2581 | P07339 | Cathepsin D | 91.72% | 98.95% |
CHEMBL2413 | P32246 | C-C chemokine receptor type 1 | 90.66% | 89.50% |
CHEMBL4026 | P40763 | Signal transducer and activator of transcription 3 | 90.53% | 82.69% |
CHEMBL299 | P17252 | Protein kinase C alpha | 90.40% | 98.03% |
CHEMBL215 | P09917 | Arachidonate 5-lipoxygenase | 90.22% | 92.68% |
CHEMBL1293249 | Q13887 | Kruppel-like factor 5 | 89.90% | 86.33% |
CHEMBL3130 | O00329 | PI3-kinase p110-delta subunit | 89.81% | 96.47% |
CHEMBL5888 | Q99558 | Mitogen-activated protein kinase kinase kinase 14 | 89.60% | 100.00% |
CHEMBL3359 | P21462 | Formyl peptide receptor 1 | 89.34% | 93.56% |
CHEMBL4203 | Q9HAZ1 | Dual specificity protein kinase CLK4 | 89.05% | 94.45% |
CHEMBL3137262 | O60341 | LSD1/CoREST complex | 88.45% | 97.09% |
CHEMBL1163125 | O60885 | Bromodomain-containing protein 4 | 88.11% | 97.31% |
CHEMBL3145 | P42338 | PI3-kinase p110-beta subunit | 87.34% | 98.75% |
CHEMBL1994 | P08235 | Mineralocorticoid receptor | 87.26% | 100.00% |
CHEMBL3045 | P05771 | Protein kinase C beta | 87.04% | 97.63% |
CHEMBL1914 | P06276 | Butyrylcholinesterase | 87.02% | 95.00% |
CHEMBL1806 | P11388 | DNA topoisomerase II alpha | 86.74% | 89.00% |
CHEMBL2274 | Q9H228 | Sphingosine 1-phosphate receptor Edg-8 | 86.67% | 100.00% |
CHEMBL3922 | P50579 | Methionine aminopeptidase 2 | 85.89% | 97.28% |
CHEMBL5163 | Q9NY46 | Sodium channel protein type III alpha subunit | 85.88% | 96.90% |
CHEMBL2094135 | Q96BI3 | Gamma-secretase | 85.68% | 98.05% |
CHEMBL5255 | O00206 | Toll-like receptor 4 | 85.51% | 92.50% |
CHEMBL1293316 | Q9HBX9 | Relaxin receptor 1 | 84.98% | 82.50% |
CHEMBL5469 | Q14289 | Protein tyrosine kinase 2 beta | 84.55% | 91.03% |
CHEMBL3437 | Q16853 | Amine oxidase, copper containing | 84.27% | 94.00% |
CHEMBL2095194 | P08709 | Coagulation factor VII/tissue factor | 83.49% | 99.17% |
CHEMBL3807 | P17706 | T-cell protein-tyrosine phosphatase | 83.41% | 93.00% |
CHEMBL5608 | Q16288 | NT-3 growth factor receptor | 83.18% | 95.89% |
CHEMBL340 | P08684 | Cytochrome P450 3A4 | 83.14% | 91.19% |
CHEMBL5619 | P27695 | DNA-(apurinic or apyrimidinic site) lyase | 81.76% | 91.11% |
CHEMBL5285 | Q99683 | Mitogen-activated protein kinase kinase kinase 5 | 81.10% | 92.26% |
CHEMBL4040 | P28482 | MAP kinase ERK2 | 80.98% | 83.82% |
CHEMBL3430907 | Q96GD4 | Aurora kinase B/Inner centromere protein | 80.77% | 97.50% |
CHEMBL4227 | P25090 | Lipoxin A4 receptor | 80.63% | 100.00% |
CHEMBL3267 | P48736 | PI3-kinase p110-gamma subunit | 80.28% | 95.71% |
Below are displayed all the plants proven (via scientific papers) to contain this
compound!
To see more specific details click the taxa you are interested in.
To see more specific details click the taxa you are interested in.
Veratrum album |
PubChem | 162820080 |
LOTUS | LTS0160953 |
wikiData | Q104888278 |